Regulation of protein stability of DNA methyltransferase 1 by post-translational modifications

Acta Biochimica et Biophysica Sinica

Volumn 46, Issue 3, 2014, Pages 199-203

  Scott, Anthony ^a   Song, Jing ^a   Ewing, Rob ^b   Wang, Zhenghe ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

DNA (cytosine 5 ) methyltransferase; epi genetics; neoplasms; post translational modification; protein stability

Indexed keywords

ANTINEOPLASTIC AGENT; AZACITIDINE; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; HYDROXAMIC ACID; VORINOSTAT;

DNA METHYLATION; DRUG ANTAGONISM; EPI-GENETICS; GENETICS; HUMAN; METABOLISM; NEOPLASM; POST-TRANSLATIONAL MODIFICATION; PROTEIN PROCESSING; PROTEIN STABILITY; REVIEW;

DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPI-GENETICS; NEOPLASMS; POST-TRANSLATIONAL MODIFICATION; PROTEIN STABILITY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZACITIDINE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; HUMANS; HYDROXAMIC ACIDS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY;

EID: 84897741221     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt146     Document Type: Review

References (72)

1. Bird A. Perceptions of epigenetics. Nature 2007, 447: 396-398.
2. Jones PA and Baylin SB. The epigenomics of cancer. Cell 2007, 128: 683-692.
3. Damelin M and Bestor TH. Biological functions of DNA methyltransferase 1 require its methyltransferase activity.Mol Cell Biol 2007, 27: 3891-3899.
4. Cedar H and Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009, 10: 295-304.
5. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL andWolffe AP. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 2000, 25: 338-342.
6. Rountree MR, Bachman KE and Baylin SB. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 2000, 25: 269-277.
7. Zhou Q, Agoston AT, Atadja P, Nelson WG and Davidson NE. Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells. Mol Cancer Res 2008, 6: 873-883.
8. Ting AH, McGarvey KM and Baylin SB. The cancer epigenome-components and functional correlates. Genes Dev 2006, 20: 3215-3231.
9. Denis H, Ndlovu MN and Fuks F. Regulation of mammalian DNA methyltransferases: A route to new mechanisms. EMBO Rep 2011, 12: 647-656.
10. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005, 6: 597-610.
11. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007, 447: 433-440.
12. Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S and Hojo K, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011, 43: 595-600.
13. Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G and Melberg A, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet 2012, 21: 2205-2210.
14. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Jr and Kinzler KW. Cancer genome landscapes. Science 2013, 339: 1546-1558.
15. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF and Isaacs WB, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995, 55: 5195-5199.
16. Jain S, Chang TT, Hamilton JP, Lin SY, Lin YJ, Evans AA and Selaru FM, et al. Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma. PLoS ONE 2011, 6: e26799.
17. Donninger H, Vos MD and Clark GJ. The RASSF1A tumor suppressor. J Cell Sci 2007, 120: 3163-3172.
18. Peng DF, Kanai Y, Sawada M, Ushijima S, Hiraoka N, Kitazawa S and Hirohashi S. DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Carcinogenesis 2006, 27: 1160-1168.
19. Holm TM, Jackson-Grusby L, Brambrink T, Yamada Y, Rideout WM, III and Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 2005, 8: 275-285.
20. De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X and Nelson WG. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res 1999, 59: 3855-3860.
21. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA and Jones PA. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999, 27: 2291-2298.
22. Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M and Kitano S, et al. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 2004, 164: 689-699.
23. Wu J, Issa JP, Herman J, Bassett DE, Jr, Nelkin BD and Baylin SB. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 1993, 90: 8891-8895.
24. Agoston AT, Argani P, Yegnasubramanian S, De Marzo AM, Ansari-Lari MA, Hicks JL and Davidson NE, et al. Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J Biol Chem 2005, 280: 18302-18310.
25. Bronner C. Control of DNMT1 abundance in epigenetic inheritance by acetylation, ubiquitylation, and the histone code. Sci Signal 2011, 4: pe3.
26. Du Z, Song J, Wang Y, Zhao Y, Guda K, Yang S and Kao HY, et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal 2010, 3: ra80.
27. Yoon JH, Choi YJ, Choi WS, Ashktorab H, Smoot DT, Nam SW and Lee JY, et al. GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle. Clin Cancer Res 2013, 19: 4599-4610.
28. Peng L, Yuan Z, Ling H, Fukasawa K, Robertson K, Olashaw N and Koomen J, et al. SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol Cell Biol 2011, 31: 4720-4734.
29. Felle M, Joppien S, Nemeth A, Diermeier S, Thalhammer V, Dobner T and Kremmer E, et al. The USP7/Dnmt1 complex stimulates the DNA methylation activity of DNMT1 and regulates the stability of UHRF1. Nucleic Acids Res 2011, 39: 8355-8365.
30. Qin W, Leonhardt H and Spada F. Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1. J Cell Biochem 2011, 112: 439-444.
31. Esteve PO, Chin HG, Benner J, Feehery GR, Samaranayake M, Horwitz GA and Jacobsen SE, et al. Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci USA 2009, 106: 5076-5081.
32. Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J and Su H, et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 2009, 41: 125-129.
33. Esteve PO, Chang Y, Samaranayake M, Upadhyay AK, Horton JR, Feehery GR and Cheng X, et al. A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability. Nat Struct Mol Biol 2011, 18: 42-48.
34. He S, Wang F, Yang L, Guo C,Wan R, Ke A and Xu L, et al. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. PLoS ONE 2011, 6: e27684.
35. Bakin AV and Curran T. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 1999, 283: 387-390.
36. Jinawath A, Miyake S, Yanagisawa Y, Akiyama Y and Yuasa Y. Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem J 2005, 385: 557-564.
37. Kimura H, Nakamura T, Ogawa T, Tanaka S and Shiota K. Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways. Nucleic Acids Res 2003, 31: 3101-3113.
38. Chuang LS, Ian HI, Koh TW, Ng HH, Xu G and Li BF. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science 1997, 277: 1996-2000.
39. Schneider K, Fuchs C, Dobay A, Rottach A, Qin W, Wolf P and A lvarez-Castro JM, et al. Dissection of cell cycle-dependent dynamics of Dnmt1 by FRAP and diffusion-coupled modeling. Nucleic Acids Res 2013, 41: 4860-4876.
40. Citterio E, Papait R, Nicassio F, Vecchi M, Gomiero P, Mantovani R and Di Fiore PP, et al. Np95 is a histone-binding protein endowed with ubiquitin ligase activity. Mol Cell Biol 2004, 24: 2526-2535.
41. Karagianni P, Amazit L, Qin J and Wong J. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol Cell Biol 2008, 28: 705-717.
42. Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA and Shinga J, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007, 450: 908-912.
43. Bostick M, Kim JK, Esteve PO, Clark A, Pradhan S and Jacobsen SE. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007, 317: 1760-1764.
44. Nishiyama A, Yamaguchi L, Sharif J, Johmura Y, Kawamura T, Nakanishi K and Shimamura S, et al. Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature 2013, 502: 249-253.
45. Shamma A, Suzuki M, Hayashi N, Kobayashi M, Sasaki N, Nishiuchi T and Doki Y, et al. ATM mediates pRB function to control DNMT1 protein stability and DNA methylation. Mol Cell Biol 2013, 33: 3113-3124.
46. Lavoie G, Esteve PO, Laulan NB, Pradhan S and St-Pierre Y. PKC isoforms interact with and phosphorylate DNMT1. BMC Biol 2011, 9: 31.
47. Hervouet E, Lalier L, Debien E, Cheray M, Geairon A, Rogniaux H and Loussouarn D, et al. Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS ONE 2010, 5: e11333.
48. Qin W, Leonhardt H and Pichler G. Regulation of DNA methyltransferase 1 by interactions and modifications. Nucleus 2011, 2: 392-402.
49. Juttermann R, Li E and Jaenisch R. Toxicity of 5-Aza-20-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA 1994, 91: 11797-11801.
50. Santi DV, Garrett CE and Barr PJ. On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell 1983, 33: 9-10.
51. Santi DV, Norment A and Garrett CE. Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-Azacytosine. Proc Natl Acad Sci USA 1984, 81: 6993-6997.
52. Goffin J and Eisenhauer E. DNA methyltransferase inhibitors-state of the art. Ann Oncol 2002, 13: 1699-1716.
53. Ghoshal K, Datta J, Majumder S, Bai S, Kutay H, Motiwala T and Jacob ST, et al. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-Adjacent homology domain, and nuclear localization signal. Mol Cell Biol 2005, 25: 4727-4741.
54. Patel K, Dickson J, Din S, Macleod K, Jodrell D and Ramsahoye B. Targeting of 5-Aza-20-deoxycytidine residues by chromatin-Associated DNMT1 induces proteasomal degradation of the free enzyme. Nucleic Acids Res 2010, 38: 4313-4324.
55. Bhalla KN. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J Clin Oncol 2005, 23: 3971-3993.
56. Karberg S. Switching on epigenetic therapy. Cell 2009, 139: 1029-1031.
57. Kaiser J. Epigenetic drugs take on cancer. Science 2010, 330: 576-578.
58. Reverdy C, Conrath S, Lopez R, Planquette C, Atmanene C, Collura V and Harpon J, et al. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chem Biol 2012, 19: 467-477.
59. Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S and Trouplin V, et al. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther 2009, 8: 2286-2295.
60. Nicholson B and Suresh Kumar KG. The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem Biophys 2011, 60: 61-68.
61. Chauhan D, Tian Z, Nicholson B, Kumar KG, Zhou B, Carrasco R and McDermott JL, et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 2012, 22: 345-358.
62. Lee HR, Choi WC, Lee S, Hwang J, Hwang E, Guchhait K and Haas J, et al. Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein. Nat Struct Mol Biol 2011, 18: 1336-1344.
63. Yamaguchi M, Miyazaki M, Kodrasov MP, Rotinsulu H, Losung F, Mangindaan RE and de Voogd NJ, et al. Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor. Bioorg Med Chem Lett 2013, 23: 3884-3886.
64. Popovic R, Shah MY and Licht JD. Epigenetic therapy of hematological malignancies: where are we now? Ther Adv Hematol 2013, 4: 81-91.
65. Brueckner B and Lyko F. DNA methyltransferase inhibitors: old and new drugs for an epigenetic cancer therapy. Trends Pharmacol Sci 2004, 25: 551-554.
66. Brueckner B, Garcia Boy R, Siedlecki P, Musch T, Kliem HC, Zielenkiewicz P and Suhai S, et al. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res 2005, 65: 6305-6311.
67. Mohammad F, Pandey GK, Mondal T, Enroth S, Redrup L, Gyllensten U and Kanduri C. Long noncoding RNA-mediated maintenance of DNA methylation and transcriptional gene silencing. Development 2012, 139: 2792-2803.
68. Mohammad F, Mondal T, Guseva N, Pandey GK and Kanduri C. Kcnq1ot1 noncoding RNA mediates transcriptional gene silencing by interacting with Dnmt1. Development 2010, 137: 2493-2499.
69. Di Ruscio A, Ebralidze AK, Benoukraf T, Amabile G, Goff LA, Terragni J and Figueroa ME, et al. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature 2013, 503: 371-376.
70. Rothbart SB, Dickson BM, Ong MS, Krajewski K, Houliston S, Kireev DB and Arrowsmith CH, et al. Multivalent histone engagement by the linked tandem Tudor and PHD domains of UHRF1 is required for the epigenetic inheritance of DNA methylation. Genes Dev 2013, 27: 1288-1298.
71. Hayashi N, Kobayashi M, Shamma A, Morimura Y, Takahashi C and Yamamoto KI. Regulatory interaction between NBS1 and DNMT1 responding to DNA damage. J Biochem 2013, 154: 429-435.
72. Espada J. Non-catalytic functions of DNMT1. Epigenetics 2012, 7: 115-118.